Trial Profile
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Active Control Study to Evaluate the Safety and Efficacy of a Single Intraoperative Administration of SKY0402 For Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2013
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 27 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2009 Planned end date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
- 06 Jan 2009 Status changed from recruiting to active, no longer recruiting, as reported by Pacira Pharmaceuticals in a company media release.